As of Apr 29
| +0.04 / +0.47%|
The 3 analysts offering 12-month price forecasts for Enzymotec Ltd have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +4.17% increase from the last price of 8.64.
The current consensus among 4 polled investment analysts is to Buy stock in Enzymotec Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.